Yigal Nochomovitz
Stock Analyst at Citigroup
(3.16)
# 1,127
Out of 4,944 analysts
308
Total ratings
42.04%
Success rate
1.76%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Yigal Nochomovitz
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AVBP ArriVent BioPharma | Maintains: Buy | $40 → $33 | $18.05 | +82.88% | 3 | Aug 12, 2025 | |
| ARCT Arcturus Therapeutics Holdings | Maintains: Buy | $47 → $49 | $19.21 | +155.08% | 6 | Aug 12, 2025 | |
| OLMA Olema Pharmaceuticals | Maintains: Buy | $20 → $21 | $5.27 | +298.48% | 2 | Aug 12, 2025 | |
| ZLAB Zai Lab | Maintains: Buy | $66 → $69 | $35.63 | +93.66% | 9 | Aug 11, 2025 | |
| BMEA Biomea Fusion | Maintains: Buy | $9 → $7 | $1.72 | +306.98% | 10 | Aug 11, 2025 | |
| ZYME Zymeworks | Maintains: Buy | $19 → $22 | $13.94 | +57.82% | 17 | Aug 11, 2025 | |
| LXRX Lexicon Pharmaceuticals | Maintains: Buy | $1.2 → $1.9 | $1.11 | +71.17% | 12 | Aug 7, 2025 | |
| SNDX Syndax Pharmaceuticals | Maintains: Buy | $46 → $51 | $13.45 | +279.18% | 9 | Aug 5, 2025 | |
| KRYS Krystal Biotech | Maintains: Neutral | $176 → $166 | $149.36 | +11.14% | 6 | Aug 5, 2025 | |
| APLS Apellis Pharmaceuticals | Maintains: Buy | $46 → $52 | $26.58 | +95.64% | 17 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $49 → $52 | $39.36 | +32.11% | 4 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sell | $7 | $20.40 | -65.69% | 1 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $9 | $2.37 | +279.75% | 2 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $14 | $6.68 | +109.58% | 1 | Jun 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $9.5 | $7.09 | +33.99% | 10 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $10 | $5.75 | +73.91% | 15 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $23 → $35 | $26.87 | +30.26% | 5 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $49 → $55 | $36.58 | +50.36% | 11 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $25 | $6.40 | +290.63% | 1 | Feb 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $89 → $82 | $57.33 | +43.03% | 21 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $33 | $11.01 | +199.73% | 1 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $89 → $97 | $67.22 | +44.30% | 16 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $8 | $0.45 | +1,671.87% | 10 | Nov 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $6 | $1.95 | +207.69% | 5 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $27 | $16.75 | +61.19% | 1 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $8 → $2 | $0.81 | +146.70% | 4 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $58 | $24.42 | +137.51% | 3 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $14 | $1.66 | +743.37% | 14 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.5 → $1.2 | $0.86 | +39.86% | 9 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $38 | $10.06 | +277.73% | 7 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $14 | $9.83 | +42.42% | 6 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.8 → $2 | $2.02 | -0.99% | 3 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $8 | $5.37 | +48.98% | 10 | Oct 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.5 → $1 | $3.47 | -71.18% | 4 | Sep 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $50 → $35 | $12.13 | +188.54% | 12 | Aug 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $130 → $133 | $28.97 | +359.10% | 15 | Jun 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $16 | $2.79 | +473.48% | 3 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $10 | $1.13 | +784.96% | 6 | Mar 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $44 | $3.41 | +1,190.32% | 2 | Sep 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $12 | $2.21 | +442.99% | 1 | Sep 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $5.30 | - | 14 | Sep 28, 2021 |
ArriVent BioPharma
Aug 12, 2025
Maintains: Buy
Price Target: $40 → $33
Current: $18.05
Upside: +82.88%
Arcturus Therapeutics Holdings
Aug 12, 2025
Maintains: Buy
Price Target: $47 → $49
Current: $19.21
Upside: +155.08%
Olema Pharmaceuticals
Aug 12, 2025
Maintains: Buy
Price Target: $20 → $21
Current: $5.27
Upside: +298.48%
Zai Lab
Aug 11, 2025
Maintains: Buy
Price Target: $66 → $69
Current: $35.63
Upside: +93.66%
Biomea Fusion
Aug 11, 2025
Maintains: Buy
Price Target: $9 → $7
Current: $1.72
Upside: +306.98%
Zymeworks
Aug 11, 2025
Maintains: Buy
Price Target: $19 → $22
Current: $13.94
Upside: +57.82%
Lexicon Pharmaceuticals
Aug 7, 2025
Maintains: Buy
Price Target: $1.2 → $1.9
Current: $1.11
Upside: +71.17%
Syndax Pharmaceuticals
Aug 5, 2025
Maintains: Buy
Price Target: $46 → $51
Current: $13.45
Upside: +279.18%
Krystal Biotech
Aug 5, 2025
Maintains: Neutral
Price Target: $176 → $166
Current: $149.36
Upside: +11.14%
Apellis Pharmaceuticals
Aug 1, 2025
Maintains: Buy
Price Target: $46 → $52
Current: $26.58
Upside: +95.64%
Aug 1, 2025
Maintains: Buy
Price Target: $49 → $52
Current: $39.36
Upside: +32.11%
Jul 24, 2025
Initiates: Sell
Price Target: $7
Current: $20.40
Upside: -65.69%
Jul 9, 2025
Maintains: Buy
Price Target: $6 → $9
Current: $2.37
Upside: +279.75%
Jun 26, 2025
Initiates: Buy
Price Target: $14
Current: $6.68
Upside: +109.58%
May 5, 2025
Maintains: Neutral
Price Target: $10 → $9.5
Current: $7.09
Upside: +33.99%
May 2, 2025
Maintains: Buy
Price Target: $11 → $10
Current: $5.75
Upside: +73.91%
Mar 26, 2025
Upgrades: Buy
Price Target: $23 → $35
Current: $26.87
Upside: +30.26%
Mar 6, 2025
Maintains: Buy
Price Target: $49 → $55
Current: $36.58
Upside: +50.36%
Feb 20, 2025
Initiates: Buy
Price Target: $25
Current: $6.40
Upside: +290.63%
Feb 18, 2025
Maintains: Buy
Price Target: $89 → $82
Current: $57.33
Upside: +43.03%
Jan 7, 2025
Initiates: Buy
Price Target: $33
Current: $11.01
Upside: +199.73%
Dec 9, 2024
Maintains: Buy
Price Target: $89 → $97
Current: $67.22
Upside: +44.30%
Nov 29, 2024
Maintains: Buy
Price Target: $13 → $8
Current: $0.45
Upside: +1,671.87%
Nov 26, 2024
Maintains: Buy
Price Target: $30 → $6
Current: $1.95
Upside: +207.69%
Oct 8, 2024
Initiates: Buy
Price Target: $27
Current: $16.75
Upside: +61.19%
Oct 2, 2024
Downgrades: Neutral
Price Target: $8 → $2
Current: $0.81
Upside: +146.70%
Aug 27, 2024
Maintains: Buy
Price Target: $60 → $58
Current: $24.42
Upside: +137.51%
Aug 15, 2024
Maintains: Buy
Price Target: $16 → $14
Current: $1.66
Upside: +743.37%
Jun 18, 2024
Maintains: Neutral
Price Target: $3.5 → $1.2
Current: $0.86
Upside: +39.86%
Jun 3, 2024
Maintains: Buy
Price Target: $36 → $38
Current: $10.06
Upside: +277.73%
May 7, 2024
Maintains: Buy
Price Target: $15 → $14
Current: $9.83
Upside: +42.42%
Apr 18, 2024
Maintains: Neutral
Price Target: $1.8 → $2
Current: $2.02
Upside: -0.99%
Oct 17, 2023
Maintains: Buy
Price Target: $25 → $8
Current: $5.37
Upside: +48.98%
Sep 18, 2023
Maintains: Neutral
Price Target: $1.5 → $1
Current: $3.47
Upside: -71.18%
Aug 21, 2023
Maintains: Sell
Price Target: $50 → $35
Current: $12.13
Upside: +188.54%
Jun 7, 2023
Maintains: Buy
Price Target: $130 → $133
Current: $28.97
Upside: +359.10%
Apr 5, 2023
Maintains: Buy
Price Target: $24 → $16
Current: $2.79
Upside: +473.48%
Mar 2, 2023
Maintains: Buy
Price Target: $9 → $10
Current: $1.13
Upside: +784.96%
Sep 16, 2022
Maintains: Buy
Price Target: $45 → $44
Current: $3.41
Upside: +1,190.32%
Sep 16, 2022
Maintains: Buy
Price Target: $16 → $12
Current: $2.21
Upside: +442.99%
Sep 28, 2021
Upgrades: Buy
Price Target: n/a
Current: $5.30
Upside: -